Preventive and therapeutic effects of ephedrine alkaloids-free Ephedra Herb extract on paclitaxel-induced neuropathic pain
Journal of Natural Medicines · 2025
DOI: 10.1007/s11418-024-01853-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Medicines, 2025. Verfasst von Xuedan Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oriental Medicine Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan. Hauptthemen laut MEDLINE: Neuralgia, Plant Extracts, Paclitaxel, Ephedra. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Agency for Medical Research and Development.
Abstract (Originalsprache)
Currently, there are no effective prophylactic or therapeutic drugs for the treatment of paclitaxel (PTX)-induced peripheral neuropathic pain (PTX-PNP), highlighting the urgent need for the development of effective prophylactic and therapeutic drugs. In this study, we initially compared the efficacy of Ephedra Herb extract (EHE) with that of ephedrine alkaloids-free Ephedra Herb extract (EFE), which lacked ephedrine alkaloids (EAs)-associated side effects, against the onset of PTX-induced mechanical allodynia, thermal hyperalgesia, and cold allodynia in mice. EHE and EFE demonstrated comparable preventive effects on the PTX-PNP in a dose-dependent manner. These results indicated that the preventive properties of EHE were independent of the EAs. Since elderly people are overwhelmingly more susceptible to developing cancer, we considered that EFE has greater benefits than EHE, so we conducted a study focused on the effects of EFE. EFE showed dose-dependent preventive effects on the onset of PTX-PNP. As a result of detailed investigation, coadministration of PTX and EFE (Co-EFE) was more effective than preadministration of EFE alone (Pre-EFE). And the effects of Co-EFE was same with the effect of preadministration of EFE and then coadministration of PTX and EFE (P&C-EFE). Additionally, Co-EFE after the onset of PTX-PNP improved PTX-induced mechanical allodynia, thermal hyperalgesia, and cold allodynia, confirming the therapeutic efficacy of EFE on PTX-PNP. In contrast, goshajinkigan, a Kampo medicine, and diclofenac, a non-steroidal anti-inflammatory drug, showed minimal therapeutic effects on PTX-PNP. These findings demonstrate the significant potential of EFE as a novel, safe prophylactic and therapeutic agent against PTX-PNP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oriental Medicine Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan.
- Oriental Medicine Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan. hyuga-s@insti.kitasato-u.ac.jp.
- National Institute of Health Sciences, Kawasaki, Japan.
Förderung
- Agency for Medical Research and Development
Zitieren
APA
Huang, X., Hyuga, S., Ito, M., Goda, Y., & Kobayashi, Y. (2025). Preventive and therapeutic effects of ephedrine alkaloids-free Ephedra Herb extract on paclitaxel-induced neuropathic pain. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01853-8
Vancouver
Huang X, Hyuga S, Ito M, Goda Y, Kobayashi Y. Preventive and therapeutic effects of ephedrine alkaloids-free Ephedra Herb extract on paclitaxel-induced neuropathic pain. Journal of Natural Medicines. 2025. doi:10.1007/s11418-024-01853-8
BibTeX
@article{Huang2025,
author = {Huang, Xuedan and Hyuga, Sumiko and Ito, Michiho and Goda, Yukihiro and Kobayashi, Yoshinori},
title = {Preventive and therapeutic effects of ephedrine alkaloids-free Ephedra Herb extract on paclitaxel-induced neuropathic pain},
journal = {Journal of Natural Medicines},
year = {2025},
doi = {10.1007/s11418-024-01853-8}
}
EUVIMED